Learn more

JUBILANT ORGANOSYS LTD

Overview
  • Total Patents
    140
About

JUBILANT ORGANOSYS LTD has a total of 140 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and chemical engineering are UK CHEMIPHARM CO LTD, ZHEJIANG HUAYI PHARMACEUTICAL CO LTD and LABORATOIRE BIODIM.

Patent filings per year

Chart showing JUBILANT ORGANOSYS LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Dubey Sushil Kumar 44
#2 Thaper Rajesh Kumar 31
#3 Mukherji Gour 26
#4 Agarwal Ashutosh 21
#5 Manjunatha Sulur G 21
#6 Kulkarni Ashok Krishna 18
#7 Khanna Jag Mohan 13
#8 Panchal Maulik Kiritkumar 11
#9 Fanda Anuj Kumar 10
#10 Bhadwal Paramvir 9

Latest patents

Publication Filing date Title
CN102030738A Novel imidazole compound, preparation method and use thereof
EP2289867A2 A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
WO2010084516A1 Process for producing optically active n-alkyl-piperidine-2-carboxanilide
CN101774966A Process for producing dihalopyridines
WO2010046932A2 Extended release pharmaceutical composition of minocycline and process thereof
WO2010041277A2 Stable pharmaceutical compositions of montelukast or its salts or solvates or hydrates
WO2010023535A1 A process for producing (s)-3-[(1-dimethylamino)ethyl] phenyl-n-ethyl-n-methyl-carbamate via novel intermediates
CN101723885A Improved method for preparing diaminopyridine
US2010285119A1 Multiparticulate Extended Release Pharmaceutical Composition Of Carbamazepine And Process For Manufacturing The Same
CN101544635A Improved method for preparing 10-halo-benzo[b][1,5]naphthyridine
US2010291225A1 Stabilized Sustained Release Composition of Bupropion Hydrochloride and Process For Preparing the Same
WO2008104996A2 Water dispersible pharmaceutical formulation and process for preparing the same
WO2008023390A2 Modified release pharmaceutical composition of bupropion hydrochloride
EP2054403A1 Process for producing sulphoxide compounds
CA2658675A1 Process for producing 10-oxo-10, 11-dihydr0-5h-dibenz [b, f] azepine-5-carboxamide starting from 5-cyanoiminostilbene
WO2008126098A1 Extended release pharmaceutical formulation of propranolol hydrochloride
WO2007144901A1 Process for stabilization of olanzapine polymorphic form i
WO2007141806A1 Pharmaceutical formulations comprising oxcarbazepine and methods thereof
WO2007129329A2 Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
WO2007108010A2 Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate